| Institution: | 1. Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research, Office of New Drugs, US Food and Drug Administration, United States;2. Office of Hematology and Oncology Products, Center for Drug Evaluation and Research, Office of New Drugs, US Food and Drug Administration, United States;3. Division of Biometrics VI, Center for Drug Evaluation and Research, Office of Biostatistics, Office of Translational Sciences, US Food and Drug Administration, United States |
